Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Armata Pharmaceuticals Inc (ARMP) USD0.01

Sell:$4.05 Buy:$0 Change: No change
Market closed |  Prices as at close on 14 October 2019 | Switch to live prices |
Sell:$4.05
Buy:$0
Change: No change
Market closed |  Prices as at close on 14 October 2019 | Switch to live prices |
Sell:$4.05
Buy:$0
Change: No change
Market closed |  Prices as at close on 14 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Armata Pharmaceuticals, Inc., formerly AmpliPhi Biosciences Corporation, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The Company is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AB-SA01 and AB-PA01.

Contact details

Address:
4503 Glencoe Ave
MARINA DEL REY
90292-6372
United States
Telephone:
+1 (310) 6652928
Website:
https://www.armatapharma.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ARMP
ISIN:
US04216R1023
Market cap:
$40.33 million
Shares in issue:
9.96 million
Sector:
Biotechnology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Jeremy Curnock-Cook
    Chairman of the Board
  • Brian Varnum
    President, Chief Development Officer
  • Todd Patrick
    Chief Executive Officer, Director
  • Steven Martin
    Chief Financial Officer
  • Igor Bilinsky
    Chief Operating Officer, Senior Vice President
  • Duane Morris
    Vice President - Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.